HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David M Findlay Selected Research

drozitumab

9/2017Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.
12/2014Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David M Findlay Research Topics

Disease

13Osteolysis
12/2019 - 10/2006
10Neoplasms (Cancer)
09/2017 - 06/2002
9Bone Resorption
01/2018 - 01/2004
7Osteosarcoma (Osteogenic Sarcoma)
09/2017 - 06/2002
7Breast Neoplasms (Breast Cancer)
03/2016 - 05/2006
6Inflammation (Inflammations)
12/2017 - 01/2005
4Hypoxia (Hypoxemia)
09/2017 - 10/2014
4Neoplasm Metastasis (Metastasis)
09/2017 - 05/2009
4Bone Diseases (Bone Disease)
01/2017 - 01/2004
3Bone Fractures (Bone Fracture)
01/2017 - 07/2004
3Osteoporosis
08/2013 - 04/2005
3Hypercalcemia (Milk Alkali Syndrome)
05/2013 - 08/2008
2Joint Diseases (Joint Disease)
01/2018 - 01/2007
2Arthralgia (Joint Pain)
01/2018 - 08/2007
2Bacterial Infections (Bacterial Infection)
04/2015 - 01/2012
2Osteoarthritis
03/2011 - 04/2005
2Rheumatoid Arthritis
03/2011 - 08/2006
2Multiple Myeloma
03/2009 - 09/2003
2Necrosis
01/2009 - 10/2006
1Osteomyelitis
01/2018
1Disease Progression
01/2018
1Infections
01/2018
1Wounds and Injuries (Trauma)
12/2016
1Osteoporotic Fractures
01/2016
1Knee Osteoarthritis
01/2016
1Bone Neoplasms (Bone Cancer)
04/2015
1Rickets (Rachitis)
10/2014
1Crush Injuries
01/2013
1Body Weight (Weight, Body)
01/2013
1Tibial Plateau Fractures
01/2013
1Arthritis (Polyarthritis)
01/2009

Drug/Important Bio-Agent (IBA)

8LigandsIBA
08/2014 - 01/2005
6Polyethylene (Polythene)IBA
01/2019 - 10/2006
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2011 - 06/2002
5CalciumIBA
09/2015 - 08/2008
4CytokinesIBA
01/2013 - 06/2002
3Pharmaceutical PreparationsIBA
12/2017 - 04/2015
3TH 302IBA
09/2017 - 02/2015
3ProdrugsIBA
09/2017 - 02/2015
3MineralsIBA
03/2016 - 01/2004
3Calcitonin Receptors (Calcitonin Receptor)IBA
09/2015 - 08/2008
3Vitamin DFDA LinkGeneric
10/2014 - 06/2007
3OsteoprotegerinIBA
08/2014 - 03/2009
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
05/2013 - 08/2008
3Messenger RNA (mRNA)IBA
07/2004 - 09/2003
2ultra-high molecular weight polyethylene (UHMWPE)IBA
01/2019 - 03/2016
2MetalsIBA
01/2019 - 10/2006
2Biological ProductsIBA
01/2018 - 02/2011
2DNA (Deoxyribonucleic Acid)IBA
09/2017 - 02/2015
2drozitumabIBA
09/2017 - 12/2014
2RANK LigandIBA
01/2017 - 10/2006
2Proteins (Proteins, Gene)FDA Link
01/2016 - 09/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015 - 12/2014
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
08/2014 - 03/2011
2Zoledronic Acid (Zometa)FDA Link
07/2010 - 05/2009
2Diphosphonates (Bisphosphonates)IBA
05/2009 - 01/2004
2Calcitriol (Calcijex)FDA LinkGeneric
08/2008 - 01/2004
2Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
10/2006 - 01/2005
1AlloysIBA
01/2019
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2019
1Cathepsin KIBA
01/2019
1titanium alloy (TiAl6V4)IBA
01/2019
1human TNFSF10 proteinIBA
09/2017
1azomycinIBA
09/2017
1isophosphamide mustard (IPAM)IBA
09/2017
1Acid PhosphataseIBA
01/2017
1Heme (Haem)IBA
01/2017
1EnzymesIBA
01/2017
1Eosinophil PeroxidaseIBA
01/2017
1Peroxidase (Myeloperoxidase)IBA
01/2017
1Parathyroid Hormone (Parathormone)IBA
12/2016
1Hormones (Hormone)IBA
12/2016
1GelsIBA
12/2016
1Paclitaxel (Taxol)FDA LinkGeneric
03/2016
1Polysaccharides (Glycans)IBA
01/2016
1Transcription Factors (Transcription Factor)IBA
10/2014
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
10/2014
1LuciferasesIBA
08/2014
1p38 Mitogen-Activated Protein KinasesIBA
01/2013
1Dihydrotachysterol (AT 10)IBA
01/2013
1TitaniumIBA
01/2012
1TWEAK ReceptorIBA
03/2011
1Neutralizing AntibodiesIBA
03/2011
1apomabIBA
10/2009
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2009
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2009
1Biotin (Vitamin H)FDA Link
01/2009
11,25-dihydroxyvitamin DIBA
08/2008

Therapy/Procedure

4Hip Replacement Arthroplasty (Total Hip Replacement)
12/2019 - 12/2013
4Prostheses and Implants (Prosthesis)
12/2019 - 10/2011
4Cell Transplantation
09/2017 - 03/2009
3Therapeutics
04/2015 - 06/2002
3Drug Therapy (Chemotherapy)
02/2015 - 06/2002
2Replacement Arthroplasty
01/2018 - 01/2007
2Bone Transplantation (Bone Grafting)
04/2014 - 01/2013
1Bone Plates (Bone Plate)
01/2018
1Bone-Implant Interface
01/2016
1Reoperation
12/2013
1Joint Prosthesis
10/2011
1Treatment Delay
10/2009